# Kailera Therapeutics, Inc.: Form SCHEDULE 13D, filed Apr 23, 2026

- Company: [Kailera Therapeutics, Inc.](/companies/klra.md) (CIK 2096997)
- Form: SCHEDULE 13D
- Filed: 2026-04-23
- Accepted by EDGAR: Apr 23, 2026, 19:34 ET
- Period: not reported
- Accession: 0001193125-26-174293
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2096997/000119312526174293/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2096997/000119312526174293/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2096997/000119312526174293/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-174293. Last ingested by Listed: Nov 4, 2026, 17:09 ET. No prices; not investment advice.